Therapeutic Asset Ratings

160 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Karxt Alzheimer Disease	Bristol-Myers Squibb	P3	CCC (52)
Xanomeline Enteric Alzheimer Disease	Bristol-Myers Squibb	P3	CCC (52)
LISPRO-PH20 COMPONENT RHUPH20 Urothelial Carcinoma	Bristol-Myers Squibb	P2	CCC (51)
cc-122 Lymphoma, Non-Hodgkin	Bristol-Myers Squibb	P1/2	CCC (51)
Iza-Bren Breast Neoplasms	Bristol-Myers Squibb	P2/3	CCC (50)
Navlimetostat Pancreatic Ductal Adenocarcinoma	Bristol-Myers Squibb	P2/3	CCC (50)
BMS 986315 NSCLC	Bristol-Myers Squibb	P2	CCC (48)
BMS-986504 Solid Tumors	Bristol-Myers Squibb	P2	CCC (48)
Daraxonrasib Solid Tumors	Bristol-Myers Squibb	P2	CCC (48)
ERIBULIN/FARLETUZUMAB ANTIBODY DRUG CONJUGATE Carcinoma, Non-Small-Cell Lung	Bristol-Myers Squibb	P2	CCC (48)
Immunoglobulin G1 [247-alanine,248-glutamic acid,250-alanine,343-serine,344-serine,de-C-terminal-lysine], anti-(human T cell immunoreceptor with Ig and ITIM domains) (human monoclonal BMS-986207 ?1-chain), disulfide with human monoclonal BMS-986207 ?-chain, dimer Non-Small Cell Lung Cancer	Bristol-Myers Squibb	P2	CCC (48)
Pumitamig Solid Tumors	Bristol-Myers Squibb	P2	CCC (48)
Bms-936558-01 Gastric/Gastroesophageal Junction Adenocarcinoma	Bristol-Myers Squibb	P1/2	CCC (48)
Bms-936558-01 Microsatellite Stable Colorectal Cancer	Bristol-Myers Squibb	P1/2	CCC (48)
BMS-986458 Relapsed/Refractory Non-Hodgkin Lymphoma	Bristol-Myers Squibb	P1/2	CCC (48)
BMS-986525 Relapsed/Refractory Small Cell Lung Cancer	Bristol-Myers Squibb	P1/2	CCC (48)
Immunoglobulin G1 [de-C-terminal-lysine], anti-(human CC chemokine receptor CCR8) (human-Mus musculus monoclonal BMS-986340 ?1-chain), disulfide with human-Mus musculus monoclonal BMS-986340 ?-chain, dimer Gastric/Gastroesophageal Junction Adenocarcinoma	Bristol-Myers Squibb	P1/2	CCC (48)
Pumitamig Advanced Renal Cell Carcinoma (RCC)	Bristol-Myers Squibb	P1/2	CCC (48)
Pumitamig Gastric/Gastroesophageal Junction Adenocarcinoma	Bristol-Myers Squibb	P1/2	CCC (48)
Admilparant Hepatic Impairment	Bristol-Myers Squibb	P1	CC (47)
Repotrectinib Hepatic Impairment	Bristol-Myers Squibb	P1	CC (47)
Bms-936558-01 Carcinoma, Renal Cell	Bristol-Myers Squibb	P1/2	CC (47)
Bms-936558-01 Non-Small-Cell Lung Cancer	Bristol-Myers Squibb	P1/2	CC (47)
Bms-936558-01 Triple Negative Breast Neoplasms	Bristol-Myers Squibb	P1/2	CC (47)
BMS-986470 Anemia, Sickle Cell	Bristol-Myers Squibb	P1/2	CC (47)

Showing 51 to 75 of 160 assets

PreviousPage 3 of 7Next